CpG-depleted adeno-associated virus vectors evade immune detection
Open Access
- 17 June 2013
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 123 (7), 2994-3001
- https://doi.org/10.1172/jci68205
Abstract
Due to their efficient transduction potential, adeno-associated virus (AAV) vectors are leading candidates for gene therapy in skeletal muscle diseases. However, immune responses toward the vector or transgene product have been observed in preclinical and clinical studies. TLR9 has been implicated in promoting AAV-directed immune responses, but vectors have not been developed to circumvent this barrier. To assess the requirement of TLR9 in promoting immunity toward AAV-associated antigens following skeletal muscle gene transfer in mice, we compared immunological responses in WT and Tlr9-deficient mice that received an AAV vector with an immunogenic capsid, AAVrh32.33. In Tlr9-deficient mice, IFN-γ T cell responses toward capsid and transgene antigen were suppressed, resulting in minimal cellular infiltrate and stable transgene expression in target muscles. These findings suggest that AAV-directed immune responses may be circumvented by depleting the ligand for TLR9 (CpG sequences) from the vector genome. Indeed, we found that CpG-depleted AAVrh32.33 vectors could establish persistent transgene expression, evade immunity, and minimize infiltration of effector cells. Thus, CpG-depleted AAV vectors could improve outcome of clinical trials of gene therapy for skeletal muscle disease.Keywords
This publication has 27 references indexed in Scilit:
- Self-complementary AAVs Induce More Potent Transgene Product-specific Immune Responses Compared to a Single-stranded GenomeMolecular Therapy, 2012
- Innate immune sensing of DNA virusesVirology, 2011
- Sustained alpha‐sarcoglycan gene expression after gene transfer in limb‐girdle muscular dystrophy, type 2DAnnals of Neurology, 2010
- Dystrophin Immunity in Duchenne's Muscular DystrophyThe New England Journal of Medicine, 2010
- Rapid, Simple, and Versatile Manufacturing of Recombinant Adeno-Associated Viral Vectors at ScaleHuman Gene Therapy, 2010
- The Pleiotropic Effects of Natural AAV Infections on Liver-directed Gene Transfer in MacaquesMolecular Therapy, 2010
- Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapyProceedings of the National Academy of Sciences of the United States of America, 2009
- Adeno-Associated Virus-Mediated Gene Transfer to Nonhuman Primate Liver Can Elicit Destructive Transgene-Specific T Cell ResponsesHuman Gene Therapy, 2009
- Pathogen Recognition and Innate ImmunityCell, 2006
- TLR signalingCell Death & Differentiation, 2006